These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23259621)

  • 41. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.
    Semplicini A
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):119-120. PubMed ID: 32207069
    [No Abstract]   [Full Text] [Related]  

  • 43. New insights into an old disease: advanced imaging in the diagnosis and management of gout.
    McQueen FM; Reeves Q; Dalbeth N
    Postgrad Med J; 2013 Feb; 89(1048):87-93. PubMed ID: 23112219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical practice. Gout.
    Neogi T
    N Engl J Med; 2011 Feb; 364(5):443-52. PubMed ID: 21288096
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiovascular Events and Gout Flares.
    Anderson JL; Knowlton KU
    JAMA; 2022 Aug; 328(5):425-426. PubMed ID: 35916865
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hyperuricemia and hypertension--an unholy alliance].
    Holzgreve H
    MMW Fortschr Med; 2011 Jul; 153(29-31):39-40. PubMed ID: 21830738
    [No Abstract]   [Full Text] [Related]  

  • 47. Understanding treatments for gout.
    Cannella AC; Mikuls TR
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Febuxostat versus allopurinol for hyperuricemia].
    Ziegler R
    Med Monatsschr Pharm; 2006 Oct; 29(10):384. PubMed ID: 17058902
    [No Abstract]   [Full Text] [Related]  

  • 49. Consider gout in patients with risk factors, regardless of age.
    Olaniyi-Leyimu BY
    Am Fam Physician; 2008 Jul; 78(2):176. PubMed ID: 18697500
    [No Abstract]   [Full Text] [Related]  

  • 50. Emerging therapies in the long-term management of hyperuricaemia and gout.
    Stamp LK; O'Donnell JL; Chapman PT
    Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in the pharmacotherapy of gout.
    Sundy JS
    Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical implications of hyperuricemia.
    Sachs L; Batra KL; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
    [No Abstract]   [Full Text] [Related]  

  • 53. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperuricemia and gout: new insights into pathogenesis and treatment.
    Pillinger MH; Rosenthal P; Abeles AM
    Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, humanistic, and economic outcomes of gout.
    Brixner DI; Ho MJ
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S459-64; quiz S465-8. PubMed ID: 16300460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recognition and management of gout and hyperuricemia.
    Yennie RH
    JAAPA; 2003 Mar; 16(3):21-4, 27-8, 31. PubMed ID: 14968523
    [No Abstract]   [Full Text] [Related]  

  • 60. Gout: an evidence-based review.
    Chen LX; Schumacher HR
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S55-62. PubMed ID: 18830092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.